AC Immune (ACIU) Cash & Equivalents Growth (3y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 36.53% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.74% |
| Sep 30, 2025 | -9.04% |
| Jun 30, 2025 | -19.93% |
| Mar 31, 2025 | -29.23% |
| Dec 31, 2024 | -22.56% |
| Sep 30, 2024 | 616.02% |
| Jun 30, 2024 | 812.60% |
| Mar 31, 2024 | 631.13% |
| Dec 31, 2023 | -20.78% |
| Sep 30, 2023 | -42.67% |
| Jun 30, 2023 | -42.44% |
| Mar 31, 2023 | -31.00% |
| Dec 31, 2022 | -44.86% |
| Sep 30, 2022 | -40.21% |
| Jun 30, 2022 | -92.53% |
| Mar 31, 2022 | -34.52% |
| Dec 31, 2021 | -17.23% |
| Dec 31, 2020 | 12.18% |
| Sep 30, 2020 | 6.64% |
| Jun 30, 2020 | 6.04% |
| Mar 31, 2020 | 11.19% |
| Dec 31, 2019 | 8.72% |
| Sep 30, 2019 | 11.39% |
| Jun 30, 2019 | 993.63% |
| Dec 31, 2018 | 26.68% |
| Dec 31, 2017 | 232.47% |